Skip to main content
Equibles

HRTIS · Herantis Pharma Oyj · Investor Relations

Use HRTIS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HRTIS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1.3380 EUR -0.0060 (-0.45%) At close · Oct 8
Rebalance outlook locked
Market Cap
35.62M EUR
Shares
26.50M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-08-20 H1/2026 Half-a year report January-June View H1 2026 report webcast here: https://herantis.videosync.fi/q2-2026/ Earnings call
2026-08-20 H1/2026 Half-a year report January-June Event
2026-07-21 Quiet period before H1/2026 report Event
2026-04-23 Annual General Meeting Shareholder meeting
2026-03-30 Notice to Convene Herantis Pharma Plc’s Annual General Meeting of Shareholders 30 March, 2026 Read more Shareholder meeting
2026-03-30 Annual Report for 2025 Event
2026-03-05 Financial Statements Release 2025 View FY 2025 report webcast here: https://herantis.videosync.fi/q4-2025/ Earnings call
2026-03-05 Deadline for submission of proposal for AGM Event
2026-02-05 Quiet period before Financial Statements Release Event

Source: https://herantis.com/investors/share-and-shareholders/